Event Sponsors

  • Miltenyi Biotec
  • Neovii
  • Gamma Biosciences
  • SmartImmune
  • Laguna Bio
  • Medexus Pharma

BioLegend

2024 Alpha/Beta T-Cell/CD19 B-Cell Depleted Haploidentical HSCT International Symposium

α/β T‑cell/CD19 B‑cell depleted haploidentical HSCT carries the hope of making stem cell transplantation safer and more accessible, giving many patients a new chance for a lifesaving cure.

Join leading specialists from around the world to discuss the latest research and clinical breakthroughs related to T-cell depleted HSCT at this two-day, hybrid event held virtually and on the Stanford School of Medicine campus at Paul Berg Hall in the Li Ka Shing Learning and Knowledge Center (LKSC), 291 Campus Drive, Stanford, CA 94043. Our aim is to facilitate intellectual discussion and explore recent advancements in the field, with the hope of paving the way for future research and collaboration.

Our previous symposium attracted over 700 attendees from academia, biotech, pharma, and the non-profit sector. We expect an even wider audience to register and participate this year.

Speakers include:

  • Selim Corbacioglu, MD, PhD, Regensburg, Bavaria, Germany
  • Christopher Dvorak, MD, University of California, San Francisco
  • Rupert Handgretinger, MD, PhD, Children’s University Hospital in Tuebingen, Germany
  • Peter Lang, MD, PhD, University of Tubingen
  • Richard O’Reilly, MD, Memorial Sloan Kettering Cancer Center
  • Michael Allen Pulsipher, MD, University of Utah
  • Bruno Silva Santos, PhD, University of Lisboa

 

The symposium is free and registration is now open. Plan to attend in person and join us for a wine and cheese reception after the event to network with fellow physician scientists, meet our sponsors and learn more about their newest technologies.

 

Miltenyi Biotech

Agenda